Anastasiou E, Lekakis J P, Alevizaki M, Papamichael C M, Megas J, Souvatzoglou A, Stamatelopoulos S F
1st Endocrine Section and Diabetes Centre, Alexandra University Hospital, Athens, Greece.
Diabetes Care. 1998 Dec;21(12):2111-5. doi: 10.2337/diacare.21.12.2111.
To assess whether otherwise healthy women with a history of gestational diabetes mellitus (GDM) may have abnormalities in endothelial function at a very early stage, before glucose intolerance occurs.
A total of 33 women with previous GDM (17 nonobese [BMI < 27] and 16 obese [BMI > or = 27]) and 19 healthy nonobese women were examined. A 75-g oral glucose tolerance test was performed, and insulin levels and biochemical parameters were also measured. Using high-resolution ultrasound, we measured vasodilatory responses of the brachial artery during reactive hyperemia (endothelium-dependent vasodilatation), and after nitroglycerin administration, an endothelium-independent vasodilator.
Flow-mediated dilatation (FMD) was significantly and equally decreased in both groups of women with previous GDM, compared with control subjects (1.6 +/- 3.7% in the nonobese GDM group and 1.6 +/- 2.5% in the obese GDM group vs. 10.3 +/- 4.4% in control subjects, P < 0.001). FMD correlated inversely with serum uric acid levels, BMI, serum total cholesterol, and basal insulin resistance (homeostasis model assessment). Nitrate-induced dilatation was significantly decreased only in the obese GDM group compared with control subjects, (21.4 +/- 5.1 vs. 27.9 +/- 9.5, P < 0.05).
Endothelial dysfunction, which is considered as a very early index of atherogenesis, is already present in both obese and nonobese women with a history of GDM, even when they have normal glucose tolerance.
评估既往有妊娠期糖尿病(GDM)史的健康女性在糖耐量异常发生之前的极早期是否存在内皮功能异常。
共检查了33例既往有GDM史的女性(17例非肥胖者[BMI<27]和16例肥胖者[BMI≥27])以及19例健康非肥胖女性。进行了75g口服葡萄糖耐量试验,并测量了胰岛素水平和生化参数。使用高分辨率超声,我们测量了反应性充血期间肱动脉的血管舒张反应(内皮依赖性血管舒张),以及在给予硝酸甘油(一种非内皮依赖性血管舒张剂)后肱动脉的血管舒张反应。
与对照组相比,两组既往有GDM史的女性的血流介导的舒张功能(FMD)均显著且同等程度降低(非肥胖GDM组为1.6±3.7%,肥胖GDM组为1.6±2.5%,而对照组为10.3±4.4%,P<0.001)。FMD与血清尿酸水平、BMI、血清总胆固醇和基础胰岛素抵抗(稳态模型评估)呈负相关。与对照组相比,仅肥胖GDM组的硝酸酯诱导的舒张功能显著降低(21.4±5.1对27.9±9.5,P<0.05)。
内皮功能障碍被认为是动脉粥样硬化发生的极早期指标,在既往有GDM史的肥胖和非肥胖女性中均已存在,即使她们的糖耐量正常。